← Back to Search

Duodenoscope with Single-use Distal Cover for Biliary Tract Cancer

Stanford hospital, Palo Alto, CA
Targeting 6 different conditionsDuodenoscope with single-use distal cover +1 moreN/ARecruitingLed by Subhas Banerjee, MDResearch Sponsored by Stanford University

Study Summary

This trial will compare the success and complication rates of two types of endoscopes currently used for a procedure called ERCP.

Eligible Conditions
  • Pancreatic Disease
  • Biliary Tract Cancer
  • Gallstone Disease
  • Biliary Disease
  • Biliary Obstruction
  • Pancreatic Cancer

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You are having an ERCP procedure done for issues with your bile ducts or pancreas.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with procedure-related adverse events
Secondary outcome measures
Ability to perform interventions
Duodenoscope imaging characteristics profile
Duodenoscope maneuverability
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Conventional DuodenoscopeActive Control1 Intervention
Patients will undergo ERCP using a conventional duodenoscope
Group II: Duodenoscope with single-use distal coverActive Control1 Intervention
Patients will undergo ERCP using a duodenoscope with a single-use distal cover

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,324 Previous Clinical Trials
17,287,358 Total Patients Enrolled
Subhas Banerjee, MDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
50 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been invited to partcipate in this clinical research?

"Indeed, clinicaltrials.gov data reveals that this research is actively recruiting patients. The trial was first posted on October 25th 2022 and has been updated recently on the 24th of October 2022. 600 participants are being sought at a single medical centre."

Answered by AI

Are there any openings to partake in this trial at present?

"In accordance with clinicaltrials.gov, this trial is actively enlisting participants; the study was posted on October 25th 2022 and its details were updated most recently on October 24th 2022."

Answered by AI
~245 spots leftby Aug 2024